TriSalus Life Sciences, Inc. (TLSI)
3.41
+0.14
(+4.28%)
USD |
NASDAQ |
May 29, 16:00
3.41
0.00 (0.00%)
After-Hours: 20:00
TriSalus Life Sciences EPS Diluted (Quarterly) : 0.0294 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Anika Therapeutics, Inc. | -0.3737 |
| Savara, Inc. | -0.1472 |
| Vericel Corp. | -0.1241 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 1.539M |
| Revenue (Quarterly) | 8.899M |
| Total Expenses (Quarterly) | 7.36M |
| Enterprise Value | 187.36M |
| Gross Profit Margin (Quarterly) | 86.18% |
| Profit Margin (Quarterly) | 17.29% |
| Earnings Yield | -41.38% |
| Normalized Earnings Yield | -43.60 |